Why Dexcom Jumped 15.9% in July
Image source: Dexcom, Inc.
Continue Reading Below
What: After a Food and Drug Administration advisory committee voted to support removing the need to confirm blood glucose measures determined by Dexcom, Inc.'s(NASDAQ: DXCM)continuous glucose monitors (CGM) with a finger stick, the company's stockrallied 15.9% last month,according toS&P Global Market Intelligence
So what:Dexcom's CGMs provide diabetics with real-time insight into blood glucose trends. However, up until now, charting of blood glucose had to be confirmed by results from a blood glucose monitor prior to patients taking action to restore their levels to their desired range.
The committee's recommendation to remove that requirement for Dexcom's monitor could clear the way toward approval of the device by Medicare, opening up a significant patient population that up until now has struggled to afford the device.
<3>More From Fool.com
Continue Reading Below
Advertisement LeBron James: The Next Warren Buffett?
Social Security: 3 Things to Know Before Taking Benefits Early
3 Social Security Secrets You Probably Don't Know
A secret billion-dollar stock opportunity
The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early in-the-know investors! To be one of them, just click here
Todd CampbellTodd owns E.B. Capital Markets, LLC. E.B. Capital's clients may have positions in the companies mentioned. Like this article? Follow him onTwitter where he goes by the handle@ebcapitalThe Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 daysconsidering a diverse range of insightsdisclosure policy